BSE Live
Oct 29, 16:01Prev. Close
442.15
Open Price
447.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 29, 15:56Prev. Close
441.85
Open Price
442.80
Bid Price (Qty.)
442.70 (50)
Offer Price (Qty.)
0.00 (0)
| Profit & Loss account of Panacea Biotec (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 309.85 | 355.04 | 255.96 | 235.05 | 336.66 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 309.85 | 355.04 | 255.96 | 235.05 | 336.66 | |
| Total Operating Revenues | 309.85 | 359.60 | 257.07 | 235.50 | 343.56 | |
| Other Income | 16.62 | 24.91 | 34.44 | 12.57 | 20.75 | |
| Total Revenue | 326.47 | 384.51 | 291.50 | 248.07 | 364.30 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 124.01 | 123.90 | 131.16 | 172.40 | 68.70 | |
| Purchase Of Stock-In Trade | 1.75 | 0.00 | 0.75 | 0.64 | 93.33 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -23.06 | 17.79 | 31.15 | -60.95 | 14.24 | |
| Employee Benefit Expenses | 97.02 | 86.53 | 71.03 | 72.50 | 59.47 | |
| Finance Costs | 15.46 | 13.78 | 10.06 | 7.04 | 7.52 | |
| Depreciation And Amortisation Expenses | 20.29 | 21.09 | 24.50 | 26.43 | 26.57 | |
| Other Expenses | 117.06 | 117.22 | 85.60 | 123.59 | 107.33 | |
| Total Expenses | 352.53 | 380.31 | 354.25 | 341.65 | 377.16 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -26.06 | 4.21 | -62.75 | -93.58 | -12.85 | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Profit/Loss Before Tax | -26.06 | 4.21 | -62.75 | -93.58 | -12.85 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | -10.83 | 0.64 | 0.00 | 0.00 | 2.27 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.00 | 0.02 | 24.79 | 0.00 | -0.71 | |
| Tax For Earlier Years | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | -10.83 | 0.66 | 24.79 | 0.00 | 1.56 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -15.23 | 3.55 | -87.54 | -93.58 | -14.41 | |
| Profit/Loss From Continuing Operations | -15.23 | 3.55 | -87.54 | -93.58 | -14.41 | |
| Profit/Loss For The Period | -15.23 | 3.55 | -87.54 | -93.58 | -14.44 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -2.49 | 0.58 | -14.29 | -15.28 | -2.35 | |
| Diluted EPS (Rs.) | -2.49 | 0.58 | -14.29 | -15.28 | -2.35 | |
| VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| STORES, SPARES AND LOOSE TOOLS | ||||||
| Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Dividend Rate (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
24.04.2025
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y
04.03.2025
Panacea Biotec Consolidated December 2024 Net Sales at Rs 163.49 crore, up 8.63% Y-o-Y
28.11.2024
Panacea Biotec Consolidated September 2024 Net Sales at Rs 147.35 crore, up 3.03% Y-o-Y